{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:47:38Z","timestamp":1782949658091,"version":"3.54.5"},"reference-count":210,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00203-023-03590-0","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:02:36Z","timestamp":1685455356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review"],"prefix":"10.1007","volume":"205","author":[{"given":"Elham","family":"Zarenezhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein T.","family":"Abdulabbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Shayaa","family":"Kareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Amin","family":"Kouhpayeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Barbaresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohrab","family":"Najafipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulbaset","family":"Mazarzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Sotoudeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolmajid","family":"Ghasemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"3590_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000508740","volume":"36","author":"A Abdullah","year":"2020","unstructured":"Abdullah A, Neurath MF, Atreya R (2020) Mild COVID-19 symptoms in an infliximab-treated ulcerative colitis patient: can ongoing anti-TNF therapy protect against the viral hyperinflammatory response and avoid aggravated outcomes? Visc Med 36:338\u2013342. https:\/\/doi.org\/10.1159\/000508740","journal-title":"Visc Med"},{"key":"3590_CR2","doi-asserted-by":"publisher","first-page":"9199190","DOI":"10.1155\/2022\/9199190","volume":"2022","author":"S Ahmed","year":"2022","unstructured":"Ahmed S et al (2022) Effect of silymarin as an adjunct therapy in combination with sofosbuvir and ribavirin in hepatitis C patients: a miniature clinical trial. Oxid Med Cell Longev 2022:9199190. https:\/\/doi.org\/10.1155\/2022\/9199190","journal-title":"Oxid Med Cell Longev"},{"key":"3590_CR3","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1053\/j.gastro.2009.11.053","volume":"138","author":"A Ahmed-Belkacem","year":"2010","unstructured":"Ahmed-Belkacem A et al (2010) Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Gastroenterol 138:1112\u20131122. https:\/\/doi.org\/10.1053\/j.gastro.2009.11.053","journal-title":"Gastroenterol"},{"key":"3590_CR4","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/v13071272","volume":"13","author":"S Andari","year":"2021","unstructured":"Andari S et al (2021) Epstein-Barr virus DNA exacerbates colitis symptoms in a mouse model of inflammatory bowel disease. Viruses 13:1272. https:\/\/doi.org\/10.3390\/v13071272","journal-title":"Viruses"},{"key":"3590_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.20524\/aog.2020.0457","volume":"33","author":"N-P Andreou","year":"2020","unstructured":"Andreou N-P, Legaki E, Gazouli M (2020) Inflammatory bowel disease pathobiology: the role of the interferon signature. Ann Gastroenterol 33:125. https:\/\/doi.org\/10.20524\/aog.2020.0457","journal-title":"Ann Gastroenterol"},{"key":"3590_CR6","doi-asserted-by":"publisher","first-page":"5870443","DOI":"10.1155\/2022\/5870443","volume":"2022","author":"AA Assiry","year":"2022","unstructured":"Assiry AA, Bhavikatti SK, Althobaiti FA, Mohamed RN, Karobari MI (2022) Evaluation of in vitro antiprotease activity of selected traditional medicinal herbs in dentistry and its in silico PASS prediction. BioMed Res Int 2022:5870443. https:\/\/doi.org\/10.1155\/2022\/5870443","journal-title":"BioMed Res Int"},{"key":"3590_CR7","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1093\/ibd\/izaa170","volume":"26","author":"M Aziz","year":"2020","unstructured":"Aziz M, Fatima R, Haghbin H, Lee-Smith W, Nawras A (2020) The incidence and outcomes of COVID-19 in IBD patients: a rapid review and meta-analysis. Inflamm Bowel Dis 26:e132\u2013e133. https:\/\/doi.org\/10.1093\/ibd\/izaa170","journal-title":"Inflamm Bowel Dis"},{"key":"3590_CR8","doi-asserted-by":"publisher","first-page":"111596","DOI":"10.1016\/j.biopha.2021.111596","volume":"140","author":"SL Badshah","year":"2021","unstructured":"Badshah SL, Faisal S, Muhammad A, Poulson BG, Emwas AH, Jaremko M (2021a) Antiviral activities of flavonoids. Biomed Pharmacother 140:111596. https:\/\/doi.org\/10.1016\/j.biopha.2021.111596","journal-title":"Biomed Pharmacother"},{"key":"3590_CR9","doi-asserted-by":"publisher","first-page":"111596","DOI":"10.1016\/j.biopha.2021.111596","volume":"140","author":"SL Badshah","year":"2021","unstructured":"Badshah SL, Faisal S, Muhammad A, Poulson BG, Emwas AH, Jaremko M (2021b) Antiviral activities of flavonoids. Biomed Pharmacother 140:111596. https:\/\/doi.org\/10.1016\/j.biopha.2021.111596","journal-title":"Biomed Pharmacother"},{"key":"3590_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14740\/gr1358","volume":"14","author":"SM Barbalho","year":"2021","unstructured":"Barbalho SM et al (2021) What do influenza and COVID-19 represent for patients with inflammatory bowel disease? Gastroenterol Res 14:1. https:\/\/doi.org\/10.14740\/gr1358","journal-title":"Gastroenterol Res"},{"key":"3590_CR11","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/gutjnl-2020-321411","volume":"69","author":"C Bezzio","year":"2020","unstructured":"Bezzio C et al (2020) Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut 69:1213\u20131217. https:\/\/doi.org\/10.1136\/gutjnl-2020-321411","journal-title":"Gut"},{"key":"3590_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1053\/j.gastro.2009.02.087","volume":"137","author":"M Biermer","year":"2009","unstructured":"Biermer M, Berg T (2009) Rapid suppression of hepatitis C viremia induced by intravenous silibinin plus ribavirin. Gastroenterol 137:390\u2013391. https:\/\/doi.org\/10.1053\/j.gastro.2009.02.087","journal-title":"Gastroenterol"},{"key":"3590_CR13","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","volume":"7","author":"S Blach","year":"2022","unstructured":"Blach S et al (2022) Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol 7:396\u2013415. https:\/\/doi.org\/10.1016\/S2468-1253(21)00472-6","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3590_CR14","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/cmi.12155","volume":"15","author":"J Blaising","year":"2013","unstructured":"Blaising J et al (2013) Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking. Cell Microbiol 15:1866\u20131882. https:\/\/doi.org\/10.1111\/cmi.12155","journal-title":"Cell Microbiol"},{"issue":"5","key":"3590_CR15","doi-asserted-by":"publisher","first-page":"e13233","DOI":"10.1111\/eci.13233","volume":"50","author":"G Bodini","year":"2020","unstructured":"Bodini G et al (2020) Concerns related to COVID-19 pandemic among patients with inflammatory bowel disease and its influence on patient management. Eur J Clin Invest 50(5):e13233. https:\/\/doi.org\/10.1111\/eci.13233","journal-title":"Eur J Clin Invest"},{"key":"3590_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/eci.13233","volume":"27","author":"P Brodin","year":"2021","unstructured":"Brodin P (2021) Immune determinants of COVID-19 disease presentation and severity. Nat Med 27:28\u201333. https:\/\/doi.org\/10.1111\/eci.13233","journal-title":"Nat Med"},{"key":"3590_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03909-8","author":"A Brunner","year":"2022","unstructured":"Brunner A et al (2022) Prevalence of abnormal Pap smear results in inflammatory bowel disease: a prospective study. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03909-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"3590_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","volume":"8","author":"J Burisch","year":"2023","unstructured":"Burisch J et al (2023) The cost of inflammatory bowel disease in high-income settings: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol 8(5):458\u2013492. https:\/\/doi.org\/10.1016\/S2468-1253(23)00003-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3590_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2020.11.019","volume":"499","author":"BFR Caetano","year":"2021","unstructured":"Caetano BFR, Jorge BAS, Mueller-Coan BG, de Oliveira DE (2021) Epstein-Barr virus microRNAs in the pathogenesis of human cancers. Cancer Lett 499:14\u201323. https:\/\/doi.org\/10.1016\/j.canlet.2020.11.019","journal-title":"Cancer Lett"},{"key":"3590_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/ibd\/izz164","volume":"26","author":"F Caldera","year":"2020","unstructured":"Caldera F et al (2020) Immunogenicity of high dose influenza vaccine for patients with inflammatory bowel disease on anti-TNF monotherapy: a randomized clinical trial. Inflamm Bowel Dis 26:593\u2013602. https:\/\/doi.org\/10.1093\/ibd\/izz164","journal-title":"Inflamm Bowel Dis"},{"key":"3590_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.antiviral.2018.07.023","volume":"158","author":"FC Camini","year":"2018","unstructured":"Camini FC et al (2018) Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress. Antiviral Res 158:8\u201312. https:\/\/doi.org\/10.1016\/j.antiviral.2018.07.023","journal-title":"Antiviral Res"},{"key":"3590_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00384-017-2752-5","volume":"32","author":"ST Campos","year":"2017","unstructured":"Campos ST, Portela FA, Tom\u00e9 L (2017) Cytomegalovirus, inflammatory bowel disease, and anti-TNF\u03b1. Int J Colorectal Dis 32:645\u2013650. https:\/\/doi.org\/10.1007\/s00384-017-2752-5","journal-title":"Int J Colorectal Dis"},{"key":"3590_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0042-6822(86)90386-7","volume":"152","author":"J Castrillo","year":"1986","unstructured":"Castrillo J, Berghe DV, Carrasco L (1986) 3-Methylquercetin is a potent and selective inhibitor of poliovirus RNA synthesis. Virol 152:219\u2013227. https:\/\/doi.org\/10.1016\/0042-6822(86)90386-7","journal-title":"Virol"},{"key":"3590_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tifs.2018.06.003","volume":"78","author":"J Chai","year":"2018","unstructured":"Chai J et al (2018) The intelligent delivery systems for bioactive compounds in foods: physicochemical and physiological conditions, absorption mechanisms, obstacles and responsive strategies. Trends Food Sci Technol 78:144\u2013154. https:\/\/doi.org\/10.1016\/j.tifs.2018.06.003","journal-title":"Trends Food Sci Technol"},{"key":"3590_CR25","doi-asserted-by":"publisher","first-page":"114906","DOI":"10.1016\/j.jpba.2022.114906","volume":"219","author":"Y Chang","year":"2022","unstructured":"Chang Y et al (2022) The metabolic profile elucidation of Lonicera japonica flos water extract and the metabolic characteristics evaluation of bioactive compounds in human gastrointestinal tract in vitro. J Pharm Biomed Anal 219:114906. https:\/\/doi.org\/10.1016\/j.jpba.2022.114906","journal-title":"J Pharm Biomed Anal"},{"key":"3590_CR26","doi-asserted-by":"publisher","first-page":"e2427","DOI":"10.1002\/rmv.2427","volume":"33","author":"HA Cheema","year":"2023","unstructured":"Cheema HA et al (2023) Quercetin for the treatment of COVID-19 patients: a systematic review and meta-analysis. Rev Med Virol 33:e2427. https:\/\/doi.org\/10.1002\/rmv.2427","journal-title":"Rev Med Virol"},{"key":"3590_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12250-015-3584-5","volume":"30","author":"Z Cheng","year":"2015","unstructured":"Cheng Z et al (2015) Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines. Virol Sin 30:261\u2013268. https:\/\/doi.org\/10.1007\/s12250-015-3584-5","journal-title":"Virol Sin"},{"key":"3590_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cyto.2019.01.001","volume":"116","author":"S-C Cheng","year":"2019","unstructured":"Cheng S-C, Wu Y-H, Huang W-C, Pang J-HS, Huang T-H, Cheng C-Y (2019) Anti-inflammatory property of quercetin through downregulation of ICAM-1 and MMP-9 in TNF-\u03b1-activated retinal pigment epithelial cells. Cytokine 116:48\u201360. https:\/\/doi.org\/10.1016\/j.cyto.2019.01.001","journal-title":"Cytokine"},{"key":"3590_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.vaccine.2017.11.027","volume":"36","author":"L Childs","year":"2018","unstructured":"Childs L, Roesel S, Tohme RA (2018) Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992\u20132015. Vaccine 36:6\u201314. https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.027","journal-title":"Vaccine"},{"key":"3590_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apjtm.2015.12.002","volume":"9","author":"K Chiow","year":"2016","unstructured":"Chiow K, Phoon M, Putti T, Tan BK, Chow VT (2016) Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection. Asian Pac J Trop Med 9:1\u20137. https:\/\/doi.org\/10.1016\/j.apjtm.2015.12.002","journal-title":"Asian Pac J Trop Med"},{"key":"3590_CR31","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3748\/wjg.v21.i6.1915","volume":"21","author":"R Ciccocioppo","year":"2015","unstructured":"Ciccocioppo R et al (2015) Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement. World J Gastroenterol 21:1915. https:\/\/doi.org\/10.3748\/wjg.v21.i6.1915","journal-title":"World J Gastroenterol"},{"key":"3590_CR32","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1365-2036.2010.04234.x","volume":"31","author":"R Cohen","year":"2010","unstructured":"Cohen R, Yu A, Wu E, Xie J, Mulani P, Chao J (2010) Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther 31:693\u2013707. https:\/\/doi.org\/10.1111\/j.1365-2036.2010.04234.x","journal-title":"Aliment Pharmacol Ther"},{"key":"3590_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5152\/imj.2018.93357","volume":"19","author":"M \u00c7olak","year":"2018","unstructured":"\u00c7olak M et al (2018) Relationship between Epstein-Barr virus (EBV) infection and viral load in immunosuppressive patients. Istanbul Med J 19:7\u201313","journal-title":"Istanbul Med J"},{"key":"3590_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01451","author":"RML Colunga Biancatelli","year":"2020","unstructured":"Colunga Biancatelli RML, Berrill M, Catravas JD, Marik PE (2020) Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19). Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.01451","journal-title":"Front Immunol"},{"key":"3590_CR35","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/eji.200425778","volume":"35","author":"M Comalada","year":"2005","unstructured":"Comalada M et al (2005) In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-\u03baB pathway. Eur J Immunol 35:584\u2013592. https:\/\/doi.org\/10.1002\/eji.200425778","journal-title":"Eur J Immunol"},{"key":"3590_CR36","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.3748\/wjg.v27.i27.4276","volume":"27","author":"V Craviotto","year":"2021","unstructured":"Craviotto V et al (2021) Viral infections in inflammatory bowel disease: tips and tricks for correct management. World J Gastroenterol 27:4276. https:\/\/doi.org\/10.3748\/wjg.v27.i27.4276","journal-title":"World J Gastroenterol"},{"key":"3590_CR37","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/bjd.20566","volume":"185","author":"D Croitoru","year":"2021","unstructured":"Croitoru D, Sibbald C, Alavi A, Brooks S, Piguet V (2021) Challenging the association of hepatitis C and pyoderma gangrenosum. Br J Dermatol 185:1047\u20131048. https:\/\/doi.org\/10.1111\/bjd.20566","journal-title":"Br J Dermatol"},{"key":"3590_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fmed.2018.00183","volume":"5","author":"G Cui","year":"2018","unstructured":"Cui G, Yuan A (2018) A systematic review of epidemiology and risk factors associated with Chinese inflammatory bowel disease. Front Med 5:183. https:\/\/doi.org\/10.3389\/fmed.2018.00183","journal-title":"Front Med"},{"key":"3590_CR39","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1128\/AAC.00759-13","volume":"57","author":"J-P Dai","year":"2013","unstructured":"Dai J-P et al (2013) Identification of 23-(s)-2-amino-3-phenylpropanoyl-silybin as an antiviral agent for influenza A virus infection in vitro and in vivo. Antimicrob Agents Themother 57:4433\u20134443. https:\/\/doi.org\/10.1128\/AAC.00759-13","journal-title":"Antimicrob Agents Themother"},{"key":"3590_CR40","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1158\/0008-5472.CAN-04-4662","volume":"65","author":"PR Davis-Searles","year":"2005","unstructured":"Davis-Searles PR et al (2005) Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells. Cancer Res 65:4448\u20134457. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4662","journal-title":"Cancer Res"},{"key":"3590_CR41","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/jvh.12551","volume":"23","author":"S DebRoy","year":"2016","unstructured":"DebRoy S et al (2016) Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy. J Viral Hepat 23:708\u2013717. https:\/\/doi.org\/10.1111\/jvh.12551","journal-title":"J Viral Hepat"},{"key":"3590_CR42","doi-asserted-by":"publisher","unstructured":"Dewi BE, Ratningpoeti E, Desti H, Angelina M (2019) In vitro and in silico study to evaluate the effectiveness of quercitrin as antiviral drug to dengue virus. In: AIP Conference Proceedings. AIP Publishing LLC, p 030004. https:\/\/doi.org\/10.1063\/1.5139341","DOI":"10.1063\/1.5139341"},{"key":"3590_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/ptr.7309","volume":"36","author":"A Di Petrillo","year":"2022","unstructured":"Di Petrillo A, Orr\u00f9 G, Fais A, Fantini MC (2022) Quercetin and its derivates as antiviral potentials: a comprehensive review. Phytother Res 36:266\u2013278. https:\/\/doi.org\/10.1002\/ptr.7309","journal-title":"Phytother Res"},{"key":"3590_CR44","doi-asserted-by":"publisher","first-page":"110947","DOI":"10.1016\/j.biopha.2020.110947","volume":"133","author":"AU Din","year":"2021","unstructured":"Din AU et al (2021) SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother 133:110947. https:\/\/doi.org\/10.1016\/j.biopha.2020.110947","journal-title":"Biomed Pharmacother"},{"issue":"23","key":"3590_CR45","doi-asserted-by":"publisher","first-page":"5772","DOI":"10.3390\/molecules25235772","volume":"25","author":"LRL Diniz","year":"2020","unstructured":"Diniz LRL, Souza MTS, Duarte ABS, Sousa DP (2020) Mechanistic aspects and therapeutic potential of quercetin against COVID-19-associated acute kidney injury. Molecules 25(23):5772. https:\/\/doi.org\/10.3390\/molecules25235772","journal-title":"Molecules"},{"key":"3590_CR46","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1053\/j.gastro.2020.08.063","volume":"160","author":"M Dougan","year":"2021","unstructured":"Dougan M, Wang Y, Rubio-Tapia A, Lim JK (2021) AGA clinical practice update on diagnosis and management of immune checkpoint inhibitor colitis and hepatitis: expert review. Gastroenterol 160:1384\u20131393. https:\/\/doi.org\/10.1053\/j.gastro.2020.08.063","journal-title":"Gastroenterol"},{"key":"3590_CR47","doi-asserted-by":"publisher","unstructured":"Dudzi\u0144ska E (2020) Single-nucleotide polymorphisms in inflammatory bowel disease. In: The Recent Topics in Genetic Polymorphisms. IntechOpen. https:\/\/doi.org\/10.1016\/j.trsl.2011.10.006","DOI":"10.1016\/j.trsl.2011.10.006"},{"key":"3590_CR48","doi-asserted-by":"publisher","first-page":"6914346","DOI":"10.1155\/2018\/6914346","volume":"2018","author":"E Dudzi\u0144ska","year":"2018","unstructured":"Dudzi\u0144ska E, Gryzinska M, Kocki J (2018) Single nucleotide polymorphisms in selected genes in inflammatory bowel disease. BioMed Res Int 2018:6914346. https:\/\/doi.org\/10.1155\/2018\/6914346","journal-title":"BioMed Res Int"},{"issue":"3","key":"3590_CR49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/antiox10030412","volume":"10","author":"K Dzi\u0105bowska-Grabias","year":"2021","unstructured":"Dzi\u0105bowska-Grabias K et al (2021) Antioxidant therapy in inflammatory bowel diseases. Antioxidants (Basel) 10(3):412. https:\/\/doi.org\/10.3390\/antiox10030412","journal-title":"Antioxidants (Basel)"},{"key":"3590_CR50","doi-asserted-by":"publisher","first-page":"54","DOI":"10.13105\/wjma.v8.i2.54","volume":"8","author":"NO e Silva","year":"2020","unstructured":"e Silva NO, de Brito BB, da Silva FAF, Santos MLC, de Melo FF (2020) Probiotics in inflammatory bowel disease: does it work? World J Meta-Anal 8:54\u201366. https:\/\/doi.org\/10.13105\/wjma.v8.i2.54","journal-title":"World J Meta-Anal"},{"key":"3590_CR51","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hep.26260","volume":"57","author":"K Esser-Nobis","year":"2013","unstructured":"Esser-Nobis K et al (2013) Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B. Hepatol 57:953\u2013963. https:\/\/doi.org\/10.1002\/hep.26260","journal-title":"Hepatol"},{"key":"3590_CR52","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1053\/j.gastro.2008.07.072","volume":"135","author":"P Ferenci","year":"2008","unstructured":"Ferenci P et al (2008) Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon\/ribavirin therapy. Gastroenterol 135:1561\u20131567. https:\/\/doi.org\/10.1053\/j.gastro.2008.07.072","journal-title":"Gastroenterol"},{"key":"3590_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7348755","author":"GL Flores","year":"2022","unstructured":"Flores GL, Mota JC, da Silva Andrade LT, Lopes RS, Bastos FI, Villar LM (2022) Performance of HCV antigen testing for the diagnosis and monitoring of antiviral treatment: a systematic review and meta-analysis. BioMed Res Int. https:\/\/doi.org\/10.1155\/2022\/7348755","journal-title":"BioMed Res Int"},{"key":"3590_CR54","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/MIB.0000000000000013","volume":"20","author":"K Fransen","year":"2014","unstructured":"Fransen K et al (2014) Correlation of genetic risk and messenger RNA expression in a Th17\/IL23 pathway analysis in inflammatory bowel disease. Inflamm Bowel Dis 20:777\u2013782. https:\/\/doi.org\/10.1097\/MIB.0000000000000013","journal-title":"Inflamm Bowel Dis"},{"key":"3590_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/ibd\/izad076","volume":"14","author":"\u00c9HFF Frederico","year":"2017","unstructured":"Frederico \u00c9HFF et al (2017) Anti-viral effects of medicinal plants in the management of dengue: a systematic review. Afr J Tradit Complement Altern Med 14:33\u201340. https:\/\/doi.org\/10.1093\/ibd\/izad076","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"3590_CR56","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jama.2012.8265","volume":"308","author":"MW Fried","year":"2012","unstructured":"Fried MW et al (2012) Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA 308:274\u2013282. https:\/\/doi.org\/10.1001\/jama.2012.8265","journal-title":"JAMA"},{"key":"3590_CR57","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16363","author":"HM Froggatt","year":"2022","unstructured":"Froggatt HM, Heaton NS (2022) Nonrespiratory sites of influenza-associated disease: mechanisms and experimental systems for continued study. FEBS J. https:\/\/doi.org\/10.1111\/febs.16363","journal-title":"FEBS J"},{"key":"3590_CR58","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.3748\/wjg.v13.i40.5317","volume":"13","author":"E Gabbay","year":"2007","unstructured":"Gabbay E et al (2007) Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial. World J Gastroenterol 13:5317","journal-title":"World J Gastroenterol"},{"key":"3590_CR59","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.antiviral.2012.03.005","volume":"94","author":"S Ganesan","year":"2012","unstructured":"Ganesan S et al (2012) Quercetin inhibits rhinovirus replication in vitro and in vivo. Antivir Res 94:258\u2013271. https:\/\/doi.org\/10.1016\/j.antiviral.2012.03.005","journal-title":"Antivir Res"},{"key":"3590_CR60","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1097\/meg.0000000000000361","volume":"27","author":"A Gauss","year":"2015","unstructured":"Gauss A et al (2015) Intestinal cytomegalovirus infection in patients hospitalized for exacerbation of inflammatory bowel disease: a 10-year tertiary referral center experience. Eur J Gastroenterol Hepatol 27:712\u2013720. https:\/\/doi.org\/10.1097\/meg.0000000000000361","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3590_CR61","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000489308","volume":"60","author":"A Ghosh","year":"2017","unstructured":"Ghosh A, Desai A, Ravi V, Narayanappa G, Tyagi BK (2017) Chikungunya virus interacts with heat shock cognate 70 protein to facilitate its entry into mosquito cell line. Intervirology 60:247\u2013262. https:\/\/doi.org\/10.1159\/000489308","journal-title":"Intervirology"},{"key":"3590_CR62","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2022.00094","author":"S Giri","year":"2022","unstructured":"Giri S et al (2022) Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis. Intest Res. https:\/\/doi.org\/10.5217\/ir.2022.00094","journal-title":"Intest Res"},{"key":"3590_CR63","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.tifs.2021.06.007","volume":"114","author":"A Gon\u00e7alves","year":"2021","unstructured":"Gon\u00e7alves A, Estevinho BN, Rocha F (2021) Methodologies for simulation of gastrointestinal digestion of different controlled delivery systems and further uptake of encapsulated bioactive compounds. Trend Food Sci Technol 114:510\u2013520. https:\/\/doi.org\/10.1016\/j.tifs.2021.06.007","journal-title":"Trend Food Sci Technol"},{"key":"3590_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1428\/jpad.2021.62","volume":"9","author":"MM Gonzales","year":"2022","unstructured":"Gonzales MM et al (2022) Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): a pilot clinical trial. J Prev Alzheimers Dis 9:22\u201329. https:\/\/doi.org\/10.1428\/jpad.2021.62","journal-title":"J Prev Alzheimers Dis"},{"key":"3590_CR65","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/j.rvsc.2010.11.010","volume":"91","author":"H Gravina","year":"2011","unstructured":"Gravina H et al (2011) In vitro assessment of the antiviral potential of trans-cinnamic acid, quercetin and morin against equid herpesvirus 1. Res Vet Sci 91:e158\u2013e162. https:\/\/doi.org\/10.1016\/j.rvsc.2010.11.010","journal-title":"Res Vet Sci"},{"key":"3590_CR66","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/path.5878","volume":"257","author":"S Gray-Rodriguez","year":"2022","unstructured":"Gray-Rodriguez S et al (2022) Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes. J Pathol 257:198\u2013217. https:\/\/doi.org\/10.1002\/path.5878","journal-title":"J Pathol"},{"key":"3590_CR67","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.jhep.2011.12.012","volume":"56","author":"J Guedj","year":"2012","unstructured":"Guedj J, Dahari H, Pohl RT, Ferenci P, Perelson AS (2012) Understanding silibinin\u2019s modes of action against HCV using viral kinetic modeling. J Hepatol 56:1019\u20131024. https:\/\/doi.org\/10.1016\/j.jhep.2011.12.012","journal-title":"J Hepatol"},{"key":"3590_CR68","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.2174\/1381612825666190829153552","volume":"25","author":"W Guo","year":"2019","unstructured":"Guo W, Gong X, Li M (2019) Quercetin actions on lipid profiles in overweight and obese individuals: a systematic review and meta-analysis. Curr Pharm Des 25:3087\u20133095. https:\/\/doi.org\/10.2174\/1381612825666190829153552","journal-title":"Curr Pharm Des"},{"key":"3590_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26071843","author":"M Hagan","year":"2021","unstructured":"Hagan M, Hayee BH, Rodriguez-Mateos A (2021) (Poly)phenols in inflammatory bowel disease and irritable bowel syndrome: a review. Molecules. https:\/\/doi.org\/10.3390\/molecules26071843","journal-title":"Molecules"},{"key":"3590_CR70","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.cgh.2020.07.036","volume":"19","author":"TP Hanrahan","year":"2021","unstructured":"Hanrahan TP, Lubel JS, Garg M (2021) Lessons from COVID-19, ACE2, and intestinal inflammation: could a virus trigger chronic intestinal inflammation? Clin Gastroenterol Hepatol 19:206. https:\/\/doi.org\/10.1016\/j.cgh.2020.07.036","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3590_CR71","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5152\/tjg.2021.191008","volume":"32","author":"H Haz\u0131r-Konya","year":"2021","unstructured":"Haz\u0131r-Konya H, Avkan-O\u011fuz V, Akp\u0131nar H, Sa\u011fol \u00d6, Say\u0131ner A (2021) Investigation of cytomegalovirus in intestinal tissue in a country with high CMV seroprevalence. Turk J Gastroenterol 32:123. https:\/\/doi.org\/10.5152\/tjg.2021.191008","journal-title":"Turk J Gastroenterol"},{"key":"3590_CR72","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10120-015-0486-z","volume":"19","author":"LM Hess","year":"2016","unstructured":"Hess LM, Michael D, Mytelka DS, Beyrer J, Liepa AM, Nicol S (2016) Chemotherapy treatment patterns, costs, and outcomes of patients with gastric cancer in the United States: a retrospective analysis of electronic medical record (EMR) and administrative claims data. Gastric Cancer 19:607\u2013615. https:\/\/doi.org\/10.1007\/s10120-015-0486-z","journal-title":"Gastric Cancer"},{"key":"3590_CR73","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","volume":"47","author":"LJ Hickson","year":"2019","unstructured":"Hickson LJ et al (2019) Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMed 47:446\u2013456. https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.069","journal-title":"EBioMed"},{"key":"3590_CR74","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/s0014-5793(97)01367-7","volume":"418","author":"PC Hollman","year":"1997","unstructured":"Hollman PC et al (1997) Relative bioavailability of the antioxidant flavonoid quercetin from various foods in man. FEBS Lett 418:152\u2013156. https:\/\/doi.org\/10.1016\/s0014-5793(97)01367-7","journal-title":"FEBS Lett"},{"key":"3590_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/00054725-200405000-00011","volume":"10","author":"DW Hommes","year":"2004","unstructured":"Hommes DW, Sterringa G, van Deventer SJ, Tytgat GN, Weel J (2004) The pathogenicity of cytomegalovirus in inflammatory bowel disease: a systematic review and evidence-based recommendations for future research. Inflamm Bowel Dis 10:245\u2013250. https:\/\/doi.org\/10.1097\/00054725-200405000-00011","journal-title":"Inflamm Bowel Dis"},{"key":"3590_CR76","doi-asserted-by":"publisher","first-page":"5352","DOI":"10.1002\/ptr.7144","volume":"35","author":"A Hosseini","year":"2021","unstructured":"Hosseini A, Razavi BM, Banach M, Hosseinzadeh H (2021) Quercetin and metabolic syndrome: a review. Phytother Res 35:5352\u20135364. https:\/\/doi.org\/10.1002\/ptr.7144","journal-title":"Phytother Res"},{"key":"3590_CR77","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.4049\/jimmunol.0903991","volume":"184","author":"R-Y Huang","year":"2010","unstructured":"Huang R-Y, Yu Y-L, Cheng W-C, OuYang C-N, Fu E, Chu C-L (2010) Immunosuppressive effect of quercetin on dendritic cell activation and function. J Immunol 184:6815\u20136821. https:\/\/doi.org\/10.4049\/jimmunol.0903991","journal-title":"J Immunol"},{"key":"3590_CR78","doi-asserted-by":"publisher","first-page":"104939","DOI":"10.1016\/j.phrs.2020.104939","volume":"158","author":"Y-F Huang","year":"2020","unstructured":"Huang Y-F, Bai C, He F, Xie Y, Zhou H (2020) Review on the potential action mechanisms of Chinese medicines in treating coronavirus disease 2019 (COVID-19). Pharm Res 158:104939. https:\/\/doi.org\/10.1016\/j.phrs.2020.104939","journal-title":"Pharm Res"},{"key":"3590_CR79","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000512152","volume":"39","author":"RH Hunt","year":"2021","unstructured":"Hunt RH et al (2021) COVID-19 and gastrointestinal disease: implications for the gastroenterologist. Digest Dis 39:119\u2013139. https:\/\/doi.org\/10.1159\/000512152","journal-title":"Digest Dis"},{"key":"3590_CR80","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.imbio.2016.11.001","volume":"222","author":"Y Ilan","year":"2017","unstructured":"Ilan Y et al (2017) A plant cell-expressed recombinant anti-TNF fusion protein is biologically active in the gut and alleviates immune-mediated hepatitis and colitis. Immunobiol 222:544\u2013551. https:\/\/doi.org\/10.1016\/j.imbio.2016.11.001","journal-title":"Immunobiol"},{"key":"3590_CR81","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3390\/pharmaceutics13111895","volume":"13","author":"K Jannat","year":"2021","unstructured":"Jannat K et al (2021) Nanotechnology applications of flavonoids for viral diseases. Pharmaceutics 13:1895. https:\/\/doi.org\/10.3390\/pharmaceutics13111895","journal-title":"Pharmaceutics"},{"key":"3590_CR82","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/itt.s282466","volume":"9","author":"A Jefremow","year":"2020","unstructured":"Jefremow A, Neurath MF (2020) All are equal, some are more equal: targeting IL 12 and 23 in IBD\u2013a clinical perspective. ImmunoTargets Ther 9:289. https:\/\/doi.org\/10.2147\/itt.s282466","journal-title":"ImmunoTargets Ther"},{"key":"3590_CR83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/17474124.2022.2032662","volume":"16","author":"A Jena","year":"2022","unstructured":"Jena A, Mishra S, Singh AK, Sekar A, Sharma V (2022) Cytomegalovirus in ulcerative colitis: an evidence-based approach to diagnosis and treatment. Expert Rev Gastroenterol Hepatol 16:109\u2013120. https:\/\/doi.org\/10.1080\/17474124.2022.2032662","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3590_CR84","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/microorganisms8071078","volume":"8","author":"A Jentzer","year":"2020","unstructured":"Jentzer A et al (2020) Cytomegalovirus and inflammatory bowel diseases (IBD) with a special focus on the link with ulcerative colitis (UC). Microorganisms 8:1078. https:\/\/doi.org\/10.3390\/microorganisms8071078","journal-title":"Microorganisms"},{"key":"3590_CR85","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/nu13020375","volume":"13","author":"H Jia","year":"2021","unstructured":"Jia H et al (2021) Quercetin alleviates oxidative damage by activating nuclear factor erythroid 2-related factor 2 signaling in porcine enterocytes. Nutrients 13:375. https:\/\/doi.org\/10.3390\/nu13020375","journal-title":"Nutrients"},{"key":"3590_CR86","first-page":"1275","volume":"43","author":"S Jimilihan","year":"2020","unstructured":"Jimilihan S et al (2020) Study on the active components in the adjuvant treatment of novel coronavirus pneumonia (COVID-19) with Jinhua Qinggan granules based on network pharmacology and molecular docking. J Chin Med Mater 43:1275\u20131283","journal-title":"J Chin Med Mater"},{"key":"3590_CR87","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/cbdd.13604","volume":"94","author":"S Jo","year":"2019","unstructured":"Jo S, Kim H, Kim S, Shin DH, Kim MS (2019) Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem Biol Drug Des 94:2023\u20132030. https:\/\/doi.org\/10.1111\/cbdd.13604","journal-title":"Chem Biol Drug Des"},{"key":"3590_CR88","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"L Jostins","year":"2012","unstructured":"Jostins L et al (2012) Host\u2013microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119\u2013124. https:\/\/doi.org\/10.1038\/nature11582","journal-title":"Nature"},{"key":"3590_CR89","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/15384101.2017.1387701","volume":"17","author":"S Ju","year":"2018","unstructured":"Ju S et al (2018) Dietary quercetin ameliorates experimental colitis in mouse by remodeling the function of colonic macrophages via a heme oxygenase-1-dependent pathway. Cell Cycle 17:53\u201363. https:\/\/doi.org\/10.1080\/15384101.2017.1387701","journal-title":"Cell Cycle"},{"key":"3590_CR90","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan GG, Windsor JW (2021) The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 18:56\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00360-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3590_CR91","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s12328-020-01319-w","volume":"14","author":"S Kato","year":"2021","unstructured":"Kato S et al (2021) Substantial Epstein-Barr virus reactivation in a case of severe refractory ulcerative colitis: a possible role in exacerbation. Clin J Gastroenterol 14:584\u2013588. https:\/\/doi.org\/10.1007\/s12328-020-01319-w","journal-title":"Clin J Gastroenterol"},{"key":"3590_CR92","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/gutjnl-2021-324388","volume":"70","author":"NA Kennedy","year":"2021","unstructured":"Kennedy NA et al (2021) Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut 70:865\u2013875. https:\/\/doi.org\/10.1136\/gutjnl-2021-324388","journal-title":"Gut"},{"key":"3590_CR93","first-page":"1","volume":"55","author":"N Khetsuriani","year":"2006","unstructured":"Khetsuriani N, LaMonte-Fowlkes A, Oberst S, Pallansch MA, Control CfD, Prevention (2006) Enterovirus surveillance\u2014United States, 1970\u20132005. MMWR Surveill Summ 55:1\u201320","journal-title":"MMWR Surveill Summ"},{"key":"3590_CR94","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","volume":"155","author":"J Kirchgesner","year":"2018","unstructured":"Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R (2018) Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterol 155:337-346.e310. https:\/\/doi.org\/10.1053\/j.gastro.2018.04.012","journal-title":"Gastroenterol"},{"key":"3590_CR95","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1099\/jmm.0.45629-0","volume":"53","author":"J Kishore","year":"2004","unstructured":"Kishore J et al (2004) Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol 53:1155\u20131160. https:\/\/doi.org\/10.1099\/jmm.0.45629-0","journal-title":"J Med Microbiol"},{"key":"3590_CR96","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/diagnostics9010003","volume":"9","author":"ASL Kjaer","year":"2018","unstructured":"Kjaer ASL, Ribberholt I, Thomsen K, Ibsen PH, Markova E, Graff J (2018) 18F-FDG PET\/CT findings in cytomegalovirus colitis. Diagnostics 9:3. https:\/\/doi.org\/10.3390\/diagnostics9010003","journal-title":"Diagnostics"},{"key":"3590_CR97","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/jmv.23193","volume":"84","author":"KL Kolho","year":"2012","unstructured":"Kolho KL, Klemola P, Simonen-Tikka ML, Ollonen ML, Roivainen M (2012) Enteric viral pathogens in children with inflammatory bowel disease. J Med Virol 84:345\u2013347. https:\/\/doi.org\/10.1002\/jmv.23193","journal-title":"J Med Virol"},{"key":"3590_CR98","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00203-022-03027-0","volume":"204","author":"A Kumari","year":"2022","unstructured":"Kumari A, Bhawal S, Kapila S, Kapila R (2022) Strain-specific effects of probiotic Lactobacilli on mRNA expression of epigenetic modifiers in intestinal epithelial cells. Arch Microbiol 204:411. https:\/\/doi.org\/10.1007\/s00203-022-03027-0","journal-title":"Arch Microbiol"},{"key":"3590_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep11421","volume":"5","author":"R Lani","year":"2015","unstructured":"Lani R et al (2015) Antiviral activity of silymarin against chikungunya virus. Sci Rep 5:1\u201310","journal-title":"Sci Rep"},{"key":"3590_CR100","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/srep11421","volume":"16","author":"G Lawlor","year":"2010","unstructured":"Lawlor G, Moss AC (2010) Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis 16:1620\u20131627. https:\/\/doi.org\/10.1038\/srep11421","journal-title":"Inflamm Bowel Dis"},{"key":"3590_CR101","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000514715","volume":"29","author":"T Leal","year":"2022","unstructured":"Leal T, Arroja B, Costa D, Ferreira C, Soares JB, Gon\u00e7alves R (2022) Colitis due to cytomegalovirus and herpes simplex type 2 as a complication of a first presentation of inflammatory bowel disease. GE Port J Gastroenterol 29:56\u201360. https:\/\/doi.org\/10.1159\/000514715","journal-title":"GE Port J Gastroenterol"},{"key":"3590_CR102","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3904\/kjim.2022.138","volume":"37","author":"JW Lee","year":"2022","unstructured":"Lee JW, Eun CS (2022) Inflammatory bowel disease in Korea: epidemiology and pathophysiology. Korean J Intern Med 37:885\u2013894. https:\/\/doi.org\/10.3904\/kjim.2022.138","journal-title":"Korean J Intern Med"},{"key":"3590_CR103","doi-asserted-by":"publisher","first-page":"396","DOI":"10.5009\/gnl210081","volume":"16","author":"JM Lee","year":"2022","unstructured":"Lee JM et al (2022) Clinical course of hepatitis B viral infection in patients undergoing anti-tumor necrosis factor \u03b1 therapy for inflammatory bowel disease. Gut Liver 16:396. https:\/\/doi.org\/10.5009\/gnl210081","journal-title":"Gut Liver"},{"key":"3590_CR104","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ptr.6268","volume":"33","author":"T Li","year":"2019","unstructured":"Li T, Li F, Liu X, Liu J, Li D (2019a) Synergistic anti-inflammatory effects of quercetin and catechin via inhibiting activation of TLR4\u2013MyD88-mediated NF-\u03baB and MAPK signaling pathways. Phytother Res 33:756\u2013767. https:\/\/doi.org\/10.1002\/ptr.6268","journal-title":"Phytother Res"},{"key":"3590_CR105","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000489996","volume":"99","author":"X Li","year":"2019","unstructured":"Li X et al (2019b) The status of Epstein-Barr virus infection in intestinal mucosa of Chinese patients with inflammatory bowel disease. Digest 99:126\u2013132. https:\/\/doi.org\/10.1159\/000489996","journal-title":"Digest"},{"key":"3590_CR106","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s00203-022-03069-4","volume":"204","author":"Q Li","year":"2022","unstructured":"Li Q, Zhou S, Wang Y, Cong J (2022) Changes of intestinal microbiota and microbiota-based treatments in IBD. Arch Microbiol 204:442. https:\/\/doi.org\/10.1007\/s00203-022-03069-4","journal-title":"Arch Microbiol"},{"key":"3590_CR107","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10620-012-2457-0","volume":"58","author":"MV Lin","year":"2013","unstructured":"Lin MV, Blonski W, Buchner AM, Reddy KR, Lichtenstein GR (2013) The influence of anti-TNF therapy on the course of chronic hepatitis C virus infection in patients with inflammatory bowel disease. Digest Dis Sci 58:1149\u20131156. https:\/\/doi.org\/10.1007\/s10620-012-2457-0","journal-title":"Digest Dis Sci"},{"key":"3590_CR108","doi-asserted-by":"publisher","first-page":"111430","DOI":"10.1016\/j.biopha.2021.111430","volume":"138","author":"A Liskova","year":"2021","unstructured":"Liskova A, Samec M, Koklesova L, Samuel SM, Zhai K, Al-Ishaq RK (2021) Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed Pharmacother 138:111430. https:\/\/doi.org\/10.1016\/j.biopha.2021.111430","journal-title":"Biomed Pharmacother"},{"key":"3590_CR109","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1136\/gutjnl-2016-312019","volume":"66","author":"C-H Liu","year":"2017","unstructured":"Liu C-H et al (2017) Highly bioavailable silibinin nanoparticles inhibit HCV infection. Gut 66:1853\u20131861","journal-title":"Gut"},{"key":"3590_CR110","doi-asserted-by":"publisher","first-page":"6131069","DOI":"10.1136\/gutjnl-2016-312019","volume":"2022","author":"M Liu","year":"2022","unstructured":"Liu M, Mao J, Zhang S (2022) Effect of intervention of probiotics in advance on Treg\/Th17 in premature mice. BioMed Res Int 2022:6131069. https:\/\/doi.org\/10.1136\/gutjnl-2016-312019","journal-title":"BioMed Res Int"},{"key":"3590_CR111","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/gut.2010.208413","volume":"59","author":"C Loras","year":"2010","unstructured":"Loras C et al (2010) Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut 59:1340. https:\/\/doi.org\/10.1136\/gut.2010.208413","journal-title":"Gut"},{"key":"3590_CR112","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/pathogens9110870","volume":"9","author":"G Losurdo","year":"2020","unstructured":"Losurdo G et al (2020) Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from Southern Italy: a case-control study. Pathogens 9:870. https:\/\/doi.org\/10.3390\/pathogens9110870","journal-title":"Pathogens"},{"key":"3590_CR113","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000024914","author":"P Luangsirithanya","year":"2021","unstructured":"Luangsirithanya P, Treewaree S, Pongpaibul A, Pausawasdi N, Limsrivilai J (2021) Cytomegalovirus enterocolitis with subsequent diagnosis of coexisting new-onset inflammatory bowel disease: two case reports and review of the literature. Medicine. https:\/\/doi.org\/10.1097\/md.0000000000024914","journal-title":"Medicine"},{"key":"3590_CR114","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2147\/idr.s149784","volume":"10","author":"Y-l Lv","year":"2017","unstructured":"Lv Y-l et al (2017) Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A meta-analysis. Infect Drug Resist 10:511. https:\/\/doi.org\/10.2147\/idr.s149784","journal-title":"Infect Drug Resist"},{"key":"3590_CR115","doi-asserted-by":"publisher","first-page":"5665778","DOI":"10.1155\/2022\/5665778","volume":"2022","author":"YL Lyu","year":"2022","unstructured":"Lyu YL, Zhou HF, Yang J, Wang FX, Sun F, Li JY (2022) Biological activities underlying the therapeutic effect of quercetin on inflammatory bowel disease. Mediators Inflamm 2022:5665778. https:\/\/doi.org\/10.1155\/2022\/5665778","journal-title":"Mediators Inflamm"},{"key":"3590_CR116","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jfca.2007.11.005","volume":"21","author":"P Maisuthisakul","year":"2008","unstructured":"Maisuthisakul P, Pasuk S, Ritthiruangdej P (2008) Relationship between antioxidant properties and chemical composition of some Thai plants. J Food Compos Anal 21:229\u2013240. https:\/\/doi.org\/10.1016\/j.jfca.2007.11.005","journal-title":"J Food Compos Anal"},{"key":"3590_CR117","first-page":"2510","volume":"7","author":"M Malaguarnera","year":"2015","unstructured":"Malaguarnera M et al (2015) Silybin-vitamin E-phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated with pegylated interferon \u03b1 and ribavirin. Am J Transl Res 7:2510","journal-title":"Am J Transl Res"},{"key":"3590_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-016-1115-z","volume":"16","author":"G Malaguarnera","year":"2016","unstructured":"Malaguarnera G et al (2016) Silybin supplementation during HCV therapy with pegylated interferon-\u03b1 plus ribavirin reduces depression and anxiety and increases work ability. BMC Psychiatr 16:1\u201310","journal-title":"BMC Psychiatr"},{"key":"3590_CR119","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.suc.2015.07.006","volume":"95","author":"TA Malik","year":"2015","unstructured":"Malik TA (2015) Inflammatory bowel disease: historical perspective, epidemiology, and risk factors. Surg Clin North Am 95:1105\u20131122. https:\/\/doi.org\/10.1016\/j.suc.2015.07.006","journal-title":"Surg Clin North Am"},{"key":"3590_CR120","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2012.09.034","volume":"58","author":"Z Mari\u00f1o","year":"2013","unstructured":"Mari\u00f1o Z et al (2013) Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period. J Hepatol 58:415\u2013420. https:\/\/doi.org\/10.1016\/j.jhep.2012.09.034","journal-title":"J Hepatol"},{"key":"3590_CR121","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.3390\/cancers14205085","volume":"14","author":"L Marongiu","year":"2022","unstructured":"Marongiu L, Venturelli S, Allgayer H (2022) Involvement of HHV-4 (Epstein\u2013Barr virus) and HHV-5 (cytomegalovirus) in inflammatory bowel disease and colorectal cancer: a meta-analysis. Cancers 14:5085. https:\/\/doi.org\/10.3390\/cancers14205085","journal-title":"Cancers"},{"key":"3590_CR122","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ibd.22976","volume":"19","author":"GM Masclee","year":"2013","unstructured":"Masclee GM, Penders J, Pierik M, Wolffs P, Jonkers D (2013) Enteropathogenic viruses: triggers for exacerbation in IBD? A prospective cohort study using real-time quantitative polymerase chain reaction. Inflamm Bowel Dis 19:124\u2013131. https:\/\/doi.org\/10.1002\/ibd.22976","journal-title":"Inflamm Bowel Dis"},{"key":"3590_CR123","doi-asserted-by":"publisher","first-page":"e41832","DOI":"10.1371\/journal.pone.0041832","volume":"7","author":"J McClure","year":"2012","unstructured":"McClure J et al (2012) Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation. PLoS One 7:e41832. https:\/\/doi.org\/10.1371\/journal.pone.0041832","journal-title":"PLoS One"},{"key":"3590_CR124","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.virol.2013.11.003","volume":"449","author":"J McClure","year":"2014","unstructured":"McClure J, Margineantu DH, Sweet IR, Polyak SJ (2014) Inhibition of HIV by Legalon-SIL is independent of its effect on cellular metabolism. Virology 449:96\u2013103. https:\/\/doi.org\/10.1016\/j.virol.2013.11.003","journal-title":"Virology"},{"key":"3590_CR125","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cgh.2014.05.026","volume":"13","author":"JD McCurdy","year":"2015","unstructured":"McCurdy JD et al (2015) A model for identifying cytomegalovirus in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 13:131\u2013137. https:\/\/doi.org\/10.1016\/j.cgh.2014.05.026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3590_CR126","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00203-022-03026-1","volume":"204","author":"ST Miri","year":"2022","unstructured":"Miri ST, Sotoodehnejadnematalahi F, Amiri MM, Pourshafie MR, Rohani M (2022) The impact of Lactobacillus and Bifidobacterium probiotic cocktail on modulation of gene expression of gap junctions dysregulated by intestinal pathogens. Arch Microbiol 204:417. https:\/\/doi.org\/10.1007\/s00203-022-03026-1","journal-title":"Arch Microbiol"},{"key":"3590_CR127","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s00535-021-01832-w","volume":"56","author":"M Miura","year":"2021","unstructured":"Miura M et al (2021) Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study). J Gastroenterol 56:1080\u20131091. https:\/\/doi.org\/10.1007\/s00535-021-01832-w","journal-title":"J Gastroenterol"},{"key":"3590_CR128","first-page":"339","volume":"6","author":"NA Molodecky","year":"2010","unstructured":"Molodecky NA, Kaplan GG (2010) Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol 6:339","journal-title":"Gastroenterol Hepatol"},{"key":"3590_CR129","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/ecco-jcc\/jjaa061","volume":"14","author":"G Monteleone","year":"2020","unstructured":"Monteleone G, Ardizzone S (2020) Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? J Crohns Colitis 14:1334\u20131336. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa061","journal-title":"J Crohns Colitis"},{"key":"3590_CR130","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/ecco-jcc\/jjaa036","volume":"14","author":"FH Mourad","year":"2020","unstructured":"Mourad FH, Hashash JG, Kariyawasam VC, Leong RW (2020) Ulcerative colitis and cytomegalovirus infection: from A to Z. J Crohns Colitis 14:1162\u20131171. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa036","journal-title":"J Crohns Colitis"},{"key":"3590_CR131","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","volume":"17","author":"C M\u00fcnz","year":"2019","unstructured":"M\u00fcnz C (2019) Latency and lytic replication in Epstein-Barr virus-associated oncogenesis. Nat Rev Microbiol 17:691\u2013700. https:\/\/doi.org\/10.1038\/s41579-019-0249-7","journal-title":"Nat Rev Microbiol"},{"key":"3590_CR132","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0167-4889(02)00328-2","volume":"1593","author":"MP Nair","year":"2002","unstructured":"Nair MP et al (2002) The flavonoid, quercetin, differentially regulates Th-1 (IFN\u03b3) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim Biophys Acta 1593:29\u201336. https:\/\/doi.org\/10.1016\/s0167-4889(02)00328-2","journal-title":"Biochim Biophys Acta"},{"key":"3590_CR133","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1007\/s10620-010-1162-0","volume":"55","author":"H Nakase","year":"2010","unstructured":"Nakase H, Yoshino T, Honzawa Y, Chiba T (2010) Low prevalence of CMV infection in patients with Crohn\u2019s disease in comparison with ulcerative colitis: effect of different immune response on prevalence of CMV infection. Digest Dis Sci 55:1498\u20131499. https:\/\/doi.org\/10.1007\/s10620-010-1162-0","journal-title":"Digest Dis Sci"},{"key":"3590_CR134","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/gutjnl-2020-321269","volume":"69","author":"MF Neurath","year":"2020","unstructured":"Neurath MF (2020) COVID-19 and immunomodulation in IBD. Gut 69:1335\u20131342. https:\/\/doi.org\/10.1136\/gutjnl-2020-321269","journal-title":"Gut"},{"key":"3590_CR135","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1134\/s0006297917130041","volume":"82","author":"O Nikonov","year":"2017","unstructured":"Nikonov O, Chernykh E, Garber M, Nikonova EY (2017) Enteroviruses: classification, diseases they cause, and approaches to development of antiviral drugs. Biochemistry (mosc) 82:1615\u20131631. https:\/\/doi.org\/10.1134\/s0006297917130041","journal-title":"Biochemistry (mosc)"},{"issue":"9","key":"3590_CR136","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.3390\/nu12092534","volume":"12","author":"P Ninfali","year":"2020","unstructured":"Ninfali P, Antonelli A, Magnani M, Scarpa ES (2020) Antiviral properties of flavonoids and delivery strategies. Nutrients 12(9):2534. https:\/\/doi.org\/10.3390\/nu12092534","journal-title":"Nutrients"},{"key":"3590_CR137","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/ecco-jcc\/jjv040","volume":"9","author":"LH Nissen","year":"2015","unstructured":"Nissen LH et al (2015) Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders. J Crohns Colitis 9:398\u2013403. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjv040","journal-title":"J Crohns Colitis"},{"key":"3590_CR138","doi-asserted-by":"crossref","unstructured":"O\u2019Connor C (2021) Cytomegalovirus (CMV) Infection and Latency. Pathogens 2021, 10, 342. In. s Note: MDPI stays neutral with regard to jurisdictional claims in published.","DOI":"10.3390\/pathogens10030342"},{"key":"3590_CR139","doi-asserted-by":"publisher","unstructured":"Ouali SE, Achkar J-P (2022) Management of hospitalized patients with inflammatory bowel disease and CMV infection or Clostridium difficile infection. Management of inpatient inflammatory bowel disease. Springer, pp 161\u2013180. https:\/\/doi.org\/10.1007\/978-1-0716-1987-2_8","DOI":"10.1007\/978-1-0716-1987-2_8"},{"key":"3590_CR140","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1002\/ptr.7084","volume":"35","author":"P Palit","year":"2021","unstructured":"Palit P, Mukhopadhyay A, Chattopadhyay D (2021) Phyto-pharmacological perspective of silymarin: a potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property. Phytother Res 35:4246\u20134257. https:\/\/doi.org\/10.1002\/ptr.7084","journal-title":"Phytother Res"},{"key":"3590_CR141","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5217\/ir.2019.09155","volume":"18","author":"S-K Park","year":"2020","unstructured":"Park S-K et al (2020) Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases. Intest Res 18:18. https:\/\/doi.org\/10.5217\/ir.2019.09155","journal-title":"Intest Res"},{"key":"3590_CR142","doi-asserted-by":"publisher","unstructured":"Patel K, Patel DK (2019) The beneficial role of rutin, a naturally occurring flavonoid in health promotion and disease prevention: a systematic review and update. Bioactive food as dietary interventions for arthritis and related inflammatory diseases. Elsevier, 457\u2013479.https:\/\/doi.org\/10.1016\/B978-0-12-813820-5.00026-X","DOI":"10.1016\/B978-0-12-813820-5.00026-X"},{"key":"3590_CR143","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1159\/000233301","volume":"50","author":"K Patton","year":"2018","unstructured":"Patton K et al (2018) Epstein-barr virus associated colitis: another mimic of IBD? Pathol 50:S142. https:\/\/doi.org\/10.1159\/000233301","journal-title":"Pathol"},{"key":"3590_CR145","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/diagnostics11061090","volume":"11","author":"FM Pavel","year":"2021","unstructured":"Pavel FM et al (2021a) Highlighting the relevance of gut microbiota manipulation in inflammatory bowel disease. Diagnostics 11:1090. https:\/\/doi.org\/10.3390\/diagnostics11061090","journal-title":"Diagnostics"},{"issue":"6","key":"3590_CR144","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.3390\/diagnostics11061090","volume":"11","author":"FM Pavel","year":"2021","unstructured":"Pavel FM et al (2021b) Highlighting the relevance of gut microbiota manipulation in inflammatory bowel disease. Diagnostics 11(6):1090. https:\/\/doi.org\/10.3390\/diagnostics11061090","journal-title":"Diagnostics"},{"key":"3590_CR146","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3748\/wjg.v17.i46.5097","volume":"17","author":"C Pavlidis","year":"2011","unstructured":"Pavlidis C, Panoutsopoulos GI, Tiniakos D, Koutsounas S, Vlachogiannakos J, Zouboulis-Vafiadis I (2011) Serum leptin and ghrelin in chronic hepatitis C patients with steatosis. World J Gastroenterol 17:5097. https:\/\/doi.org\/10.3748\/wjg.v17.i46.5097","journal-title":"World J Gastroenterol"},{"key":"3590_CR147","doi-asserted-by":"publisher","first-page":"100033","DOI":"10.1016\/j.jve.2021.100033","volume":"7","author":"X Peng","year":"2021","unstructured":"Peng X et al (2021) Differences in HIV burden in the inflamed and non-inflamed colon from a person living with HIV and ulcerative colitis. J Virus Erad 7:100033. https:\/\/doi.org\/10.1016\/j.jve.2021.100033","journal-title":"J Virus Erad"},{"key":"3590_CR148","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2019.04.016","volume":"157","author":"D Piovani","year":"2019","unstructured":"Piovani D, Danese S, Peyrin-Biroulet L, Nikolopoulos GK, Lytras T, Bonovas S (2019) Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterol 157:647-659.e644. https:\/\/doi.org\/10.1053\/j.gastro.2019.04.016","journal-title":"Gastroenterol"},{"key":"3590_CR149","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1053\/j.gastro.2007.02.038","volume":"132","author":"SJ Polyak","year":"2007","unstructured":"Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DYW (2007) Inhibition of T-cell inflammatory cytokines, hepatocyte NF-\u03baB signaling, and HCV infection by standardized silymarin. Gastroenterology 132:1925\u20131936. https:\/\/doi.org\/10.1053\/j.gastro.2007.02.038","journal-title":"Gastroenterology"},{"key":"3590_CR150","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0002-9343(61)90105-x","volume":"30","author":"RD Powell","year":"1961","unstructured":"Powell RD, Warner NE, Levine RS, Kirsner JB (1961) Cytomegalic inclusion disease and ulcerative colitis: report of a case in a young adult. Am J Med 30:334\u2013340. https:\/\/doi.org\/10.1016\/0002-9343(61)90105-x","journal-title":"Am J Med"},{"key":"3590_CR151","doi-asserted-by":"publisher","first-page":"617980","DOI":"10.3389\/fped.2021.617980","volume":"9","author":"MG Puoti","year":"2021","unstructured":"Puoti MG, Rybak A, Kiparissi F, Gaynor E, Borrelli O (2021) SARS-CoV-2 and the gastrointestinal tract in children. Front Pediatr 9:617980. https:\/\/doi.org\/10.3389\/fped.2021.617980","journal-title":"Front Pediatr"},{"key":"3590_CR152","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/0972-9062.217617","volume":"54","author":"I Qaddir","year":"2017","unstructured":"Qaddir I, Rasool N, Hussain W, Mahmood S (2017) Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies. J Vector Borne Dis 54:255. https:\/\/doi.org\/10.4103\/0972-9062.217617","journal-title":"J Vector Borne Dis"},{"key":"3590_CR153","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s11655-012-1026-x","volume":"21","author":"M Rastegarpanah","year":"2015","unstructured":"Rastegarpanah M et al (2015) A randomized, double blinded, placebo-controlled clinical trial of silymarin in ulcerative colitis. Chin J Integr Med 21:902\u2013906. https:\/\/doi.org\/10.1007\/s11655-012-1026-x","journal-title":"Chin J Integr Med"},{"key":"3590_CR154","doi-asserted-by":"publisher","first-page":"4595","DOI":"10.1158\/1078-0432.ccr-10-1213","volume":"16","author":"K Ravichandran","year":"2010","unstructured":"Ravichandran K, Velmurugan B, Gu M, Singh RP, Agarwal R (2010) Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A\/J mice. Clin Cancer Res 16:4595\u20134606. https:\/\/doi.org\/10.1158\/1078-0432.ccr-10-1213","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3590_CR155","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41424-018-0049-9","volume":"9","author":"HG Reddy","year":"2018","unstructured":"Reddy HG, Schneider BJ, Tai AW (2018) Immune checkpoint inhibitor-associated colitis and hepatitis. Clin Transl Gastroenterol 9(9):180. https:\/\/doi.org\/10.1038\/s41424-018-0049-9","journal-title":"Clin Transl Gastroenterol"},{"key":"3590_CR156","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/tri.12324","volume":"27","author":"M Rendina","year":"2014","unstructured":"Rendina M et al (2014) Antiviral activity and safety profile of silibinin in HCV patients with advanced fibrosis after liver transplantation: a randomized clinical trial. Transpl Int 27:696\u2013704. https:\/\/doi.org\/10.1111\/tri.12324","journal-title":"Transpl Int"},{"key":"3590_CR157","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3389\/fmicb.2016.00979","volume":"7","author":"A Rivi\u00e8re","year":"2016","unstructured":"Rivi\u00e8re A, Selak M, Lantin D, Leroy F, De Vuyst L (2016) Bifidobacteria and butyrate-producing colon bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol 7:979. https:\/\/doi.org\/10.3389\/fmicb.2016.00979","journal-title":"Front Microbiol"},{"key":"3590_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep31777","volume":"6","author":"\u00c1 Rojas","year":"2016","unstructured":"Rojas \u00c1 et al (2016) Effect of quercetin on hepatitis C virus life cycle: from viral to host targets. Sci Rep 6:1\u20139. https:\/\/doi.org\/10.1038\/srep31777","journal-title":"Sci Rep"},{"key":"3590_CR159","doi-asserted-by":"publisher","first-page":"5445291","DOI":"10.1155\/2022\/5445291","volume":"2022","author":"A Roy","year":"2022","unstructured":"Roy A et al (2022) Flavonoids a bioactive compound from medicinal plants and its therapeutic applications. BioMed Res Int 2022:5445291. https:\/\/doi.org\/10.1155\/2022\/5445291","journal-title":"BioMed Res Int"},{"key":"3590_CR160","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1111\/bph.15395","volume":"178","author":"F Ruiz","year":"2021","unstructured":"Ruiz F et al (2021) A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease. Br J Pharmacol 178:3157\u20133175. https:\/\/doi.org\/10.1111\/bph.15395","journal-title":"Br J Pharmacol"},{"key":"3590_CR161","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3851\/imp1942","volume":"16","author":"K Rutter","year":"2011","unstructured":"Rutter K et al (2011) Intravenous silibinin as \u2018rescue treatment\u2019for on-treatment non-responders to pegylated interferon\/ribavirin combination therapy. Antivir Ther 16:1327\u20131333. https:\/\/doi.org\/10.3851\/imp1942","journal-title":"Antivir Ther"},{"key":"3590_CR162","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s10620-012-2116-5","volume":"57","author":"JL Ryan","year":"2012","unstructured":"Ryan JL et al (2012) Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa. Dig Dis Sci 57:1887\u20131898. https:\/\/doi.org\/10.1007\/s10620-012-2116-5","journal-title":"Dig Dis Sci"},{"key":"3590_CR163","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1017\/S0043933917000538","volume":"73","author":"M Saeed","year":"2017","unstructured":"Saeed M et al (2017) Silymarin: a potent hepatoprotective agent in poultry industry. World\u2019s Poultry Sci J 73:483\u2013492. https:\/\/doi.org\/10.1017\/S0043933917000538","journal-title":"World\u2019s Poultry Sci J"},{"key":"3590_CR164","doi-asserted-by":"publisher","first-page":"2273000","DOI":"10.1155\/2022\/2273000","volume":"2022","author":"S Safarpour","year":"2022","unstructured":"Safarpour S et al (2022) Protective effect of kaempferol and its nanoparticles on 5-fluorouracil-induced cardiotoxicity in rats. BioMed Res Int 2022:2273000. https:\/\/doi.org\/10.1155\/2022\/2273000","journal-title":"BioMed Res Int"},{"key":"3590_CR165","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.3748\/wjg.v23.i28.5097","volume":"23","author":"A Salaritabar","year":"2017","unstructured":"Salaritabar A et al (2017) Therapeutic potential of flavonoids in inflammatory bowel disease: a comprehensive review. World J Gastroenterol 23:5097. https:\/\/doi.org\/10.3748\/wjg.v23.i28.5097","journal-title":"World J Gastroenterol"},{"key":"3590_CR166","doi-asserted-by":"publisher","first-page":"e0200546","DOI":"10.1371\/journal.pone.0200546","volume":"13","author":"N Salloum","year":"2018","unstructured":"Salloum N et al (2018) Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9. PLoS One 13:e0200546. https:\/\/doi.org\/10.1371\/journal.pone.0200546","journal-title":"PLoS One"},{"key":"3590_CR167","doi-asserted-by":"publisher","first-page":"655054","DOI":"10.3389\/fphar.2021.655054","volume":"12","author":"C Schmidt","year":"2021","unstructured":"Schmidt C, Grunert PC, Stallmach A (2021) An update for pharmacologists on new treatment options for inflammatory bowel disease: the clinicians\u2019 perspective. Front Pharmacol 12:655054. https:\/\/doi.org\/10.3389\/fphar.2021.655054","journal-title":"Front Pharmacol"},{"key":"3590_CR168","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00535-015-1064-1","volume":"50","author":"D Sheehan","year":"2015","unstructured":"Sheehan D, Moran C, Shanahan F (2015) The microbiota in inflammatory bowel disease. J Gastroenterol 50:495\u2013507","journal-title":"J Gastroenterol"},{"key":"3590_CR169","doi-asserted-by":"publisher","first-page":"394","DOI":"10.2147\/jir.s116088","volume":"51","author":"T Shukla","year":"2017","unstructured":"Shukla T, Singh S, Tandon P, McCurdy JD (2017) Corticosteroids and thiopurines, but not tumor necrosis factor antagonists, are associated with cytomegalovirus reactivation in inflammatory bowel disease. J Clin Gastroenterol 51:394\u2013401. https:\/\/doi.org\/10.2147\/jir.s116088","journal-title":"J Clin Gastroenterol"},{"key":"3590_CR170","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol H et al (2017) Fungal microbiota dysbiosis in IBD. Gut 66:1039\u20131048. https:\/\/doi.org\/10.1136\/gutjnl-2015-310746","journal-title":"Gut"},{"key":"3590_CR171","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.phymed.2011.01.026","volume":"18","author":"J Song","year":"2011","unstructured":"Song J, Choi H (2011) Silymarin efficacy against influenza A virus replication. Phytomedicine 18:832\u2013835. https:\/\/doi.org\/10.1016\/j.phymed.2011.01.026","journal-title":"Phytomedicine"},{"key":"3590_CR172","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3748\/wjg.v28.i26.3092","volume":"28","author":"K Song","year":"2022","unstructured":"Song K, Wu D (2022) Shared decision-making in the management of patients with inflammatory bowel disease. World J Gastroenterol 28:3092\u20133100. https:\/\/doi.org\/10.3748\/wjg.v28.i26.3092","journal-title":"World J Gastroenterol"},{"key":"3590_CR173","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s0002-9440(10)64516-6","volume":"157","author":"T Spieker","year":"2000","unstructured":"Spieker T, Herbst H (2000) Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am J Pathol 157:51\u201357. https:\/\/doi.org\/10.1016\/s0002-9440(10)64516-6","journal-title":"Am J Pathol"},{"key":"3590_CR174","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3389\/fimmu.2017.00838","volume":"8","author":"D Statovci","year":"2017","unstructured":"Statovci D, Aguilera M, MacSharry J, Melgar S (2017) The impact of western diet and nutrients on the microbiota and immune response at mucosal interfaces. Front Immunol 8:838. https:\/\/doi.org\/10.3389\/fimmu.2017.00838","journal-title":"Front Immunol"},{"key":"3590_CR175","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.jfma.2018.07.005","volume":"118","author":"H-J Su","year":"2019","unstructured":"Su H-J et al (2019) Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc 118:1083\u20131092. https:\/\/doi.org\/10.1016\/j.jfma.2018.07.005","journal-title":"J Formos Med Assoc"},{"key":"3590_CR176","first-page":"1797","volume":"7","author":"X Sun","year":"2020","unstructured":"Sun X, Zhang Y, Liu Y, Wang G (2020) Study on mechanism of Reduning Injection in treating novel coronavirus pneumonia based on network pharmacology. J Chin Med Mater 7:1797\u20131798","journal-title":"J Chin Med Mater"},{"key":"3590_CR177","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7025634","author":"D Sun","year":"2022","unstructured":"Sun D, Li C, Chen S, Zhang X (2022) Emerging role of dendritic cell intervention in the treatment of inflammatory bowel disease. BioMed Res Int. https:\/\/doi.org\/10.1155\/2022\/7025634","journal-title":"BioMed Res Int"},{"key":"3590_CR178","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.dld.2004.06.015","volume":"36","author":"M Tanamly","year":"2004","unstructured":"Tanamly M et al (2004) Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis 36:752\u2013759. https:\/\/doi.org\/10.1016\/j.dld.2004.06.015","journal-title":"Dig Liver Dis"},{"key":"3590_CR179","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/v13010104","volume":"13","author":"G Tarris","year":"2021","unstructured":"Tarris G, de Rougemont A, Charkaoui M, Michiels C, Martin L, Belliot G (2021) Enteric viruses and inflammatory bowel disease. Viruses 13:104. https:\/\/doi.org\/10.3390\/v13010104","journal-title":"Viruses"},{"key":"3590_CR180","doi-asserted-by":"publisher","first-page":"101625","DOI":"10.1016\/j.clinre.2021.101625","volume":"45","author":"T Temtem","year":"2021","unstructured":"Temtem T, Whitworth J, Zhang J, Bagga B (2021) Cytomegalovirus in pediatric inflammatory bowel disease patients with acute severe colitis. Clin Res Hepatol Gastroenterol 45:101625. https:\/\/doi.org\/10.1016\/j.clinre.2021.101625","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3590_CR181","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2174\/1570162x19666210611145635","volume":"19","author":"E Then","year":"2021","unstructured":"Then E et al (2021) The impact of human immunodeficiency virus (HIV) on inflammatory bowel disease (IBD): a retrospective nationwide study. Curr HIV Res 19:411\u2013419. https:\/\/doi.org\/10.2174\/1570162x19666210611145635","journal-title":"Curr HIV Res"},{"key":"3590_CR182","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","volume":"63","author":"C Tillack","year":"2014","unstructured":"Tillack C et al (2014) Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-\u03b3-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment. Gut 63:567\u2013577. https:\/\/doi.org\/10.1136\/gutjnl-2012-302853","journal-title":"Gut"},{"key":"3590_CR183","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/ibd\/izy243","volume":"25","author":"A Tinsley","year":"2019","unstructured":"Tinsley A et al (2019) Increased risk of influenza and influenza-related complications among 140,480 patients with inflammatory bowel disease. Inflamm Bowel Dis 25:369\u2013376. https:\/\/doi.org\/10.1093\/ibd\/izy243","journal-title":"Inflamm Bowel Dis"},{"key":"3590_CR184","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbrep.2018.03.003","volume":"14","author":"T Umetsu","year":"2018","unstructured":"Umetsu T et al (2018) Inhibitory effect of silibinin on hepatitis B virus entry. Biochem Biophys Rep 14:20\u201325. https:\/\/doi.org\/10.1016\/j.bbrep.2018.03.003","journal-title":"Biochem Biophys Rep"},{"key":"3590_CR185","doi-asserted-by":"publisher","first-page":"3645038","DOI":"10.1155\/2022\/3645038","volume":"2022","author":"S Vazifeh","year":"2022","unstructured":"Vazifeh S, Kananpour P, Khalilpour M, Eisalou SV, Hamblin MR (2022) Anti-inflammatory and immunomodulatory properties of Lepidium sativum. BioMed Res Int 2022:3645038. https:\/\/doi.org\/10.1155\/2022\/3645038","journal-title":"BioMed Res Int"},{"key":"3590_CR186","doi-asserted-by":"publisher","first-page":"173448","DOI":"10.1016\/j.ejphar.2020.173448","volume":"886","author":"BG Vijayakumar","year":"2020","unstructured":"Vijayakumar BG, Ramesh D, Joji A, Kannan T (2020) In silico pharmacokinetic and molecular docking studies of natural flavonoids and synthetic indole chalcones against essential proteins of SARS-CoV-2. Eur J Pharmacol 886:173448. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173448","journal-title":"Eur J Pharmacol"},{"key":"3590_CR187","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.4459","volume":"235","author":"M Vockerodt","year":"2015","unstructured":"Vockerodt M et al (2015) The Epstein-Barr virus and the pathogenesis of lymphoma. J Pathol 235:312\u2013322. https:\/\/doi.org\/10.1002\/path.4459","journal-title":"J Pathol"},{"key":"3590_CR188","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1002\/hep.23587","volume":"51","author":"J Wagoner","year":"2010","unstructured":"Wagoner J et al (2010) Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology 51:1912\u20131921. https:\/\/doi.org\/10.1002\/hep.23587","journal-title":"Hepatology"},{"key":"3590_CR189","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","volume":"20","author":"KL Wallace","year":"2014","unstructured":"Wallace KL, Zheng L-B, Kanazawa Y, Shih DQ (2014) Immunopathology of inflammatory bowel disease. World J Gastroenterol 20:6. https:\/\/doi.org\/10.3748\/wjg.v20.i1.6","journal-title":"World J Gastroenterol"},{"key":"3590_CR190","doi-asserted-by":"publisher","first-page":"e1009210","DOI":"10.1371\/journal.ppat.1009210","volume":"17","author":"N Wallaschek","year":"2021","unstructured":"Wallaschek N et al (2021) Ephrin receptor A2, the epithelial receptor for Epstein-Barr virus entry, is not available for efficient infection in human gastric organoids. PLoS pathog 17:e1009210. https:\/\/doi.org\/10.1371\/journal.ppat.1009210","journal-title":"PLoS pathog"},{"key":"3590_CR191","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bcp.2018.07.039","volume":"155","author":"K Wang","year":"2018","unstructured":"Wang K, Lv Q, Miao YM, Qiao SM, Dai Y, Wei ZF (2018) Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR\/Nrf2\/NQO1 pathway. Biochem Pharmacol 155:494\u2013509. https:\/\/doi.org\/10.1016\/j.bcp.2018.07.039","journal-title":"Biochem Pharmacol"},{"key":"3590_CR192","first-page":"772","volume":"43","author":"L Wang","year":"2020","unstructured":"Wang L et al (2020) Study on the network pharmacology and preliminary evidence of Lianhua Qingwen in the treatment of novel coronavirus (2019-nCoV) pneumonia. J Chinese Med Mater 43:772\u2013778","journal-title":"J Chinese Med Mater"},{"issue":"Part 2","key":"3590_CR193","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.semcancer.2021.10.004","volume":"86","author":"Z Wang","year":"2021","unstructured":"Wang Z, Guo K, Liu Y, Huang C, Wu M (2021) Dynamic impact of virome on colitis and colorectal cancer: immunity, inflammation, prevention and treatment. Semin Cancer Biol 86(Part 2):943\u2013954. https:\/\/doi.org\/10.1016\/j.semcancer.2021.10.004","journal-title":"Semin Cancer Biol"},{"key":"3590_CR194","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/2050640619889763","volume":"8","author":"A Wisniewski","year":"2020","unstructured":"Wisniewski A et al (2020) Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines. United Eur Gastroenterol J 8:303\u2013313. https:\/\/doi.org\/10.1177\/2050640619889763","journal-title":"United Eur Gastroenterol J"},{"key":"3590_CR195","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1158\/0008-5472.can-07-2450","volume":"68","author":"Y-F Wu","year":"2008","unstructured":"Wu Y-F et al (2008) Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice. Cancer Res 68:2033\u20132042. https:\/\/doi.org\/10.1158\/0008-5472.can-07-2450","journal-title":"Cancer Res"},{"issue":"1","key":"3590_CR196","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/v8010006","volume":"8","author":"W Wu","year":"2015","unstructured":"Wu W et al (2015) Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry. Viruses 8(1):6. https:\/\/doi.org\/10.3390\/v8010006","journal-title":"Viruses"},{"key":"3590_CR197","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1097\/meg.0000000000001474","volume":"31","author":"S Wu","year":"2019","unstructured":"Wu S, He C, Tang T-Y, Li Y-Q (2019) A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease. Eur J Gastroenterol Hepatol 31:1085\u20131091. https:\/\/doi.org\/10.1097\/meg.0000000000001474","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3590_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-020-01395-9","volume":"20","author":"W Xu","year":"2020","unstructured":"Xu W et al (2020) Chronic active Epstein-Barr virus infection involving gastrointestinal tract mimicking inflammatory bowel disease. BMC Gastroenterol 20:1\u20137. https:\/\/doi.org\/10.1186\/s12876-020-01395-9","journal-title":"BMC Gastroenterol"},{"key":"3590_CR199","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12913-015-1253-x","volume":"16","author":"S Yajima","year":"2016","unstructured":"Yajima S, Shimizu H, Sakamaki H, Ikeda S, Ikegami N, Murayama JI (2016) Real-world cost analysis of chemotherapy for colorectal cancer in Japan: detailed costs of various regimens during the entire course of chemotherapy. BMC Health Serv Res 16:2. https:\/\/doi.org\/10.1186\/s12913-015-1253-x","journal-title":"BMC Health Serv Res"},{"key":"3590_CR200","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1093\/ibd\/izab358","volume":"28","author":"H Yang","year":"2022","unstructured":"Yang H, Qian J (2022) Current status of cytomegalovirus colitis among patients with inflammatory bowel disease in China: a questionnaire-based multicenter study. Inflamm Bowel Dis 28:S45\u2013S51. https:\/\/doi.org\/10.1093\/ibd\/izab358","journal-title":"Inflamm Bowel Dis"},{"key":"3590_CR201","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41579-021-00630-8","volume":"19","author":"H Yang","year":"2021","unstructured":"Yang H, Rao Z (2021) Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat Rev Microbiol 19:685\u2013700. https:\/\/doi.org\/10.1038\/s41579-021-00630-8","journal-title":"Nat Rev Microbiol"},{"key":"3590_CR202","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.immuni.2016.03.009","volume":"44","author":"J-Y Yang","year":"2016","unstructured":"Yang J-Y et al (2016) Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-\u03b2 production. Immunity 44:889\u2013900. https:\/\/doi.org\/10.1016\/j.immuni.2016.03.009","journal-title":"Immunity"},{"key":"3590_CR203","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.intimp.2017.11.013","volume":"54","author":"Y Yang","year":"2018","unstructured":"Yang Y, Zhang X, Xu M, Wu X, Zhao F, Zhao C (2018) Quercetin attenuates collagen-induced arthritis by restoration of Th17\/Treg balance and activation of Heme Oxygenase 1-mediated anti-inflammatory effect. Int Immunopharmacol 54:153\u2013162. https:\/\/doi.org\/10.1016\/j.intimp.2017.11.013","journal-title":"Int Immunopharmacol"},{"key":"3590_CR204","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bcp.2008.03.020","volume":"76","author":"ES Yu","year":"2008","unstructured":"Yu ES, Min HJ, An SY, Won HY, Hong JH, Hwang ES (2008) Regulatory mechanisms of IL-2 and IFN\u03b3 suppression by quercetin in T helper cells. Biochem Pharmacol 76:70\u201378. https:\/\/doi.org\/10.1016\/j.bcp.2008.03.020","journal-title":"Biochem Pharmacol"},{"key":"3590_CR205","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1007\/s00705-017-3417-y","volume":"162","author":"H Zakaryan","year":"2017","unstructured":"Zakaryan H, Arabyan E, Oo A, Zandi K (2017) Flavonoids: promising natural compounds against viral infections. Arch Virol 162:2539\u20132551. https:\/\/doi.org\/10.1007\/s00705-017-3417-y","journal-title":"Arch Virol"},{"key":"3590_CR206","doi-asserted-by":"publisher","first-page":"1001055","DOI":"10.3389\/fimmu.2022.1001055","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhao S, Cao Z (2022) Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease. Front Immunol 13:1001055. https:\/\/doi.org\/10.3389\/fimmu.2022.1001055","journal-title":"Front Immunol"},{"key":"3590_CR207","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00384-019-03400-4","volume":"34","author":"Y Zhou","year":"2019","unstructured":"Zhou Y et al (2019) EBV-associated lymphoproliferative disorder involving the gastrointestinal tract which mimic IBD in immunocompetent patients: case reports and literature review. Int J Colorectal Dis 34:1989\u20131993. https:\/\/doi.org\/10.1007\/s00384-019-03400-4","journal-title":"Int J Colorectal Dis"},{"key":"3590_CR208","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.ijbiomac.2021.05.031","volume":"183","author":"L Zhou","year":"2021","unstructured":"Zhou L et al (2021) Electrospun chitosan oligosaccharide\/polycaprolactone nanofibers loaded with wound-healing compounds of rutin and quercetin as antibacterial dressings. Int J Biol Macromol 183:1145\u20131154. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.05.031","journal-title":"Int J Biol Macromol"},{"key":"3590_CR209","doi-asserted-by":"publisher","first-page":"153736","DOI":"10.1016\/j.phymed.2021.153736","volume":"92","author":"H Zou","year":"2021","unstructured":"Zou H, Ye H, Kamaraj R, Zhang T, Zhang J, Pavek P (2021) A review on pharmacological activities and synergistic effect of quercetin with small molecule agents. Phytomedicine 92:153736. https:\/\/doi.org\/10.1016\/j.phymed.2021.153736","journal-title":"Phytomedicine"},{"key":"3590_CR210","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17474124.2019.1565993","volume":"13","author":"S Zullow","year":"2019","unstructured":"Zullow S, Farraye FA (2019) Updates on vaccinating the inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol 13:229\u2013239. https:\/\/doi.org\/10.1080\/17474124.2019.1565993","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-023-03590-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-023-03590-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:11:28Z","timestamp":1744161088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-023-03590-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":210,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["3590"],"URL":"https:\/\/doi.org\/10.1007\/s00203-023-03590-0","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"15 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors confirm that this article content has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"252"}}